NTLA Stock Analysis: Buy, Sell, or Hold?
NTLA - Intellia Therapeutics, Inc
$13.09
-1.19 (-8.33%)
▼
5d:
-4.52%
30d:
-12.38%
90d:
+12.65%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Accumulation
NTLA is down 4.5% this week, but smart money is accumulating calls. Top strike: $18 2026-07-17 with 5,984 OI. Call ratio: 88% View Scanner →
Strength: 6.1/10
Get Alerted When NTLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
9 traders called NTLA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NTLA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: NTLA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: NTLA is currently trading at $13.09, which is considered oversold relative to its 30-day fair value range of $13.16 to $14.96.
Technical Outlook: Technically, NTLA is in a uptrend. The price is currently testing key support at $12.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.55 (+102.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NTLA is in a uptrend. The price is currently testing key support at $12.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.55 (+102.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.16 -
$14.96
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.3%)
- BULLISH: Trading 102.8% below Wall St target ($26.55)
Trading Range Analysis
30-Day Trading Range
$13.16 -
$14.96
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$15.55
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.95
Wall Street Target
$26.55
(+102.8%)
Revenue Growth (YoY)
-9.5%
Share & Embed Analysis
Last updated: May 14, 2026 8:19 PM ET
Data refreshes hourly during market hours. Next update: 9:19 PM
Data refreshes hourly during market hours. Next update: 9:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTLA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Birgit C Schultes
SELL
8508 shares
2026-01-05
James Basta
SELL
10397 shares
2026-01-05
John M Leonard
SELL
34146 shares
2026-01-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 66 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 54 HOLD |
Advanced NTLA Option Strategies
Professional options setups generated by AI based on today's NTLA price and gamma walls.
